Change search
ReferencesLink to record
Permanent link

Direct link
Long-term outcomes among noncuratively treated men according to Prostate Cancer risk category in a nationwide, population-based study
Show others and affiliations
2013 (English)In: European Urology, ISSN 0302-2838, E-ISSN 1873-7560, Vol. 63, no 1, 88-96 p.Article in journal (Refereed) Published
Abstract [en]

Background: Limited data exist on long-term outcomes among men with prostate cancer (PCa) from population-based cohorts incorporating information on clinical risk category. Objective: To assess 15-yr mortality for men with PCa treated with noncurative intent according to clinical stage, Gleason score (GS), serum levels of prostate specific antigen (PSA), comorbidity, and age. Design, setting, and participants: Register-based cohort study of 76 437 cases in the National Prostate Cancer Register (NPCR) of Sweden diagnosed from 1991 through 2009 and treated with noncurative intent. Each case was placed in one of five risk categories: (1) low risk: T1-T2 tumor, PSA level <10 ng/ml, and GS <= 6; (2) intermediate risk: T1-T2 tumor and PSA level 10-<20 ng/ml or GS 7; (3) high risk: T3 tumor or PSA level 20-<50 ng/ml or GS >= 8; (4) regional metastases: N1 or T4 tumor or PSA level 50-100 ng/ml; and (5) distant metastases: M1 tumor or PSA >= 100 ng/ml. Outcome measurements and statistical analysis: Ten-and 15-yr cumulative risk of death after diagnosis from PCa, cardiovascular disease, and other causes. Results and limitations: Among men with a Charlson Comorbidity Index (CCI) score of 0, no differences were found in observed versus expected all-cause mortality in the low-risk group. Observed mortality was only slightly greater in the intermediate-risk group, but men with high-risk localized PCa or more advanced disease had substantially higher mortality than expected. CCI was strongly associated with cumulative 10-yr mortality from causes other than PCa, especially for men <65 yr. Limitations include potential misclassification in risk category due to GS assignment. Conclusions: PCa mortality rates vary 10-fold according to risk category. The risk of death from causes other than PCa is most strongly related to comorbidity status in younger men. (C) 2012 European Association of Urology. Published by Elsevier B. V. All rights reserved.

Place, publisher, year, edition, pages
Amsterdam, Netherlands: Elsevier, 2013. Vol. 63, no 1, 88-96 p.
Keyword [en]
Epidemiology, Risk categories, Prostate cancer mortality, All-cause mortality, Comorbidity
National Category
Cancer and Oncology
URN: urn:nbn:se:umu:diva-63755DOI: 10.1016/j.eururo.2012.08.001ISI: 000312004100015OAI: diva2:585645
Available from: 2013-01-10 Created: 2013-01-07 Last updated: 2013-01-10Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full text

Search in DiVA

By author/editor
Stattin, Pär
By organisation
Urology and Andrology
In the same journal
European Urology
Cancer and Oncology

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 41 hits
ReferencesLink to record
Permanent link

Direct link